SGLT2 inhibitor: clinical trials recruiting now
9
Recruiting trials
15
Conditions studied
25
US states with sites
5
Countries
Phase breakdown
Phase 1 1
Phase 3 1
Phase 4 3
Not applicable 4
Conditions being studied
Recruiting trials involving SGLT2 inhibitor
- Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
- Effect of Sodium Glucose Co-tansporter 2 Inhibitors (SGLT2I) on Inflammatory and Oxidative Stress Markers Level in Heart Failure Patients
- Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
- Mechanism of SGLT2 Inhibition in the Kidney
- PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
- Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
- SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning
- SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
- Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
Common questions
How many recruiting trials involve SGLT2 inhibitor?
9 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.